Doxorubicin hydrochloride 20 MG Injection — RxCUI 1872062
RxNorm drug concept · Semantic clinical drug
RxCUI 1872062
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1872062
Official nameDoxorubicin hydrochloride 20 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDOXOrubicin HCl 20 MG Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Doxorubicin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Doxorubicin is well-known for its potential to damage the heart muscle over time — a condition called cardiomyopathy. The higher the total amount you receive over your lifetime, th...
- Why is my doctor monitoring my heart so closely while I'm on this drug?
- It's a real but uncommon risk. A small number of people who receive doxorubicin — especially when combined with other DNA-damaging chemotherapy drugs or radiation — have gone on to...
- I've heard this drug can cause leukemia later. Should I be worried?
🕸️ Concept Web — How Doxorubicin hydrochloride 20 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Doxorubicin hydrochloride 20 MG Injection
RxCUI 1872062 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Doxorubicin
3639IN -
Doxorubicin hydrochloride
142433PIN
-
Doxorubicin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Doxorubicin Injection
1790094SCDF -
Doxorubicin hydrochloride Injection
2645409SCDFP -
Doxorubicin Injectable Product
1160774SCDG -
Doxorubicin hydrochloride Injectable Product
2662060SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Doxorubicin Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Doxorubicin hydrochloride 20 MG
1872061SCDC
-
Doxorubicin hydrochloride 20 MG
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Doxorubicin hydrochloride 20 MG
SCDC · 1872061 -
Doxorubicin Injection
SCDF · 1790094 -
Doxorubicin hydrochloride Injection
SCDFP · 2645409 -
Doxorubicin Injectable Product
SCDG · 1160774 -
Doxorubicin hydrochloride Injectable Product
SCDGP · 2662060
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 1872062 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70121-1218-07 | 10 CARTON in 1 CARTON (70121-1218-7) / 1 VIAL in 1 CARTON (... | Doxorubicin Hydrochloride | Amneal Pharmaceuticals LLC | 2017-02-17 |
| 70121-1219-01 | 1 VIAL in 1 CARTON (70121-1219-1) / 25 mL in 1 VIAL | Doxorubicin Hydrochloride | Amneal Pharmaceuticals LLC | 2017-02-17 |
Observed labelers:
Amneal Pharmaceuticals LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.